These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8543307)

  • 1. Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas.
    Ittmann MM; Wieczorek R
    Hum Pathol; 1996 Jan; 27(1):28-34. PubMed ID: 8543307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms.
    Lai S; Benedict WF; Silver SA; El-Naggar AK
    Hum Pathol; 1997 Jun; 28(6):693-7. PubMed ID: 9191003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors associated with loss of heterozygosity at the RB1 locus in retinoblastoma.
    Munier FL; Thonney F; Balmer A; Uffer S; Héon E; Van Melle G; Rutz HP; Pescia G; Schorderet DF
    Ophthalmic Genet; 1997 Mar; 18(1):7-12. PubMed ID: 9134545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
    Cairns P; Proctor AJ; Knowles MA
    Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation.
    Newcomb EW; Thomas A; Selkirk A; Lee SY; Potmesil M
    Cancer Res; 1995 May; 55(10):2044-7. PubMed ID: 7743499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
    Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
    Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
    O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
    Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas.
    Sarkar FH; Sakr W; Li YW; Macoska J; Ball DE; Crissman JD
    Prostate; 1992; 21(2):145-52. PubMed ID: 1329054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
    Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
    Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
    Ittmann M; Wieczorek R; Heller P; Dave A; Provet J; Krolewski J
    Am J Pathol; 1994 Aug; 145(2):287-93. PubMed ID: 8053489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
    Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
    Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression.
    Xu HJ; Cairns P; Hu SX; Knowles MA; Benedict WF
    Int J Cancer; 1993 Mar; 53(5):781-4. PubMed ID: 8449603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
    Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
    Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma.
    Walther MM; Gnarra JR; Elwood L; Xu HJ; Florence C; Anglard P; Hu SX; King C; Trahan E; Hurley K
    J Urol; 1995 Jun; 153(6):2050-4. PubMed ID: 7752392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
    Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.